NeurAxis

Click Here ???? https://lnkd.in/gCniyRzG to read the Gastrojournal.org article.

"Life-changing." That’s how Erin P. describes the impact IB-Stim had on her 12 year old son, Liam. “This device is life changing. Liam had his longest span of manageable to no pain for almost three months. I got to watch Liam riding his bike to his friends houses, climbing trees, regaining independence, finishing three Harry Potter books, and so much more! He was able to trick or treat, celebrate Diwali, Christmas, take winter MAP tests. His raw scores rose 10 points from fall (when he was in pain) to winter (no pain). It is really life changing what IBS does for families.” When asked: “How did IB-Stim help alleviate your child’s functional abdominal pain associated with IBS?” Erin said, “Reduced pain significantly. Reduced constipation. Increased his ability to go to school.” Stories like Liam’s highlight the meaningful impact IB-Stim can have on pediatric patients with functional abdominal pain related to IBS. ?? Learn more: https://ibstim.com For important IB-Stim information, including indications, precautions, and contraindications, visit https://lnkd.in/gtDShryk Disclaimer: This page contains an unpaid testimonial from a real-life IB-Stim patient’s parent/guardian. Their personal experience reflects their particular outcome, and results may vary from person to person. NeurAxis does not recommend or suggest the use of its Percutaneous Electrical Nerve Field Stimulation (PENFS) IB-Stim device for uses beyond those that are cleared by the U.S. FDA. #IBStim #IBS #PediatricGI #FunctionalAbdominalPain #IBSRelief #NeurAxis #ChronicPain ?#IBSTreatment #PENFS #DGBI #Healthcare

Up to 40% of patients with chronic constipation are unsatisfied with their current treatment1. Many continue to experience symptoms because the root cause isn’t just slow motility—it’s pelvic floor dysfunction. The Rectal Expulsion Device (RED) is a proprietary, self-inflating balloon designed to help gastroenterologists evaluate a patient’s ability to expel stool and assess rectal hypersensitivity. By improving diagnostic accuracy, RED can help doctors determine the right interventions rather than relying solely on laxative based therapies. A precise diagnosis leads to better treatment planning. See how RED is helping physicians refine their approach to chronic constipation management. Learn more: https://lnkd.in/gxGYcDAF For important RED information, including indications, precautions, and contraindications, visit https://lnkd.in/gxGYcDAF 1 Source: https://lnkd.in/gyDEkntT #Gastroenterology #GI #PelvicFloorDysfunction #DigestiveHealth #ChronicConstipation #RED #NeurAxis #ChronicPain

The NeurAxis Guidance and Patient Support (GPS) Program continues to impact families by providing support and resources for access to IB-Stim therapy for children and adolescents ages 8-21 suffering from functional abdominal pain associated with IBS. Since launching, GPS has: ??Helped 2,150 patients?navigate insurance and financial assistance ? Partnered with?69 institutions?nationwide ? Assisted?350 patients?with?prior authorization services?in 2024 alone (more than tripling from 2023!) ? Referred?776 patients?to financial assistance programs this year This incredible?growth and impact?wouldn’t be possible without our dedicated healthcare partners. Thank you for helping us ensure that?no child is left behind due to financial barriers. Learn more about how GPS can support your patients:?https://lnkd.in/g-YCQ4dB For important IB-Stim information, including risks, indications, and precautions, visit: https://lnkd.in/gW6wcdPC #IBStim #PediatricGI #FunctionalAbdominalPain #IBS #GutHealth #NeurAxis #PediatricCare #IBSSymptoms #IBSDilemma #IBSawareness #IrritableBowelSyndrome #ChildIBS #IBSRelief #IBSTreatment #PENFS #DGBI #HealthcareExcellence #Neuromodulation #ChronicPain

A New Way to Evaluate Chronic Constipation For many patients, chronic constipation isn’t just about motility—it can be about pelvic floor dysfunction. When traditional laxatives fail, the underlying issue is often neuromuscular function, making proper assessment essential. The Rectal Expulsion Device (RED) provides a new way to evaluate patients by mimicking the feel of stool in the rectum. By assessing both pelvic floor dysfunction and rectal hypersensitivity, RED helps guide treatment decisions that go beyond symptom management. Watch the video to see how RED is transforming the approach to chronic constipation. Learn more: https://lnkd.in/gc9mD_Wa For important RED information, including indications, precautions, and contraindications, visit https://lnkd.in/gxGYcDAF #Gastroenterology #GI #MotilityDisorders #DigestiveHealth #PelvicFloorDysfunction #ChronicConstipation #RED #NeurAxis #HealthcareInnovation

At?NeurAxis, we believe every child suffering from?functional abdominal pain associated with IBS?should have access to the care they need. The?Guidance and Patient Support (GPS) Program?continues to grow, helping more families navigate?insurance coverage, financial assistance, and prior authorization services. ???2024 Highlights: ??866?total GPS referrals (34% increase from 2023) ??776?patients referred to financial assistance programs ??350?patients supported with?prior authorization services?(up from 103 in 2023) ??17 new facilities?made referrals to GPS Through GPS, we are making IB-Stim?more accessible?to families nationwide. Learn more about how GPS can support your patients: ???https://lnkd.in/g-YCQ4dB ???For important IB-Stim information, including risks, indications, and precautions, visit: https://lnkd.in/gW6wcdPC #IBStim #PediatricGI #FunctionalAbdominalPain #IBS #GutHealth #NeurAxis #PediatricCare #IBSSymptoms #IBSDilemma #IBSawareness #IrritableBowelSyndrome #ChildIBS #IBSRelief #IBSTreatment #PENFS #DGBI #HealthcareExcellence #Neuromodulation #ChronicPain

Welcome, University of Vermont Children's Hospital!?NeurAxis is excited to recognize?Dr. Jillian Sullivan, Nicole Guy, RN, Lauren Haskins, NP, Dr. Michael D’Amico, and Dr. Nina Gulchowski?as the latest providers offering?IB-Stim?in their facility. IB-Stim is?FDA-cleared for adolescents (ages 8–21) with functional abdominal pain associated with IBS, offering a non-drug, non-surgical option for pediatric patients. We’re proud to see more institutions providing innovative solutions to support children’s health. Learn more about the University of Vermont Children's Hospital Pediatric Gastroenterology team:?https://lnkd.in/g983U9-Y For important IB-Stim information, including risks, indications, and precautions, visit:https://lnkd.in/gW6wcdPC #IBStim #PediatricGI #FunctionalAbdominalPain #IBS #GutHealth #NeurAxis #PediatricCare #IBSSymptoms #IBSDilemma #IBSawareness #IrritableBowelSyndrome #ChildIBS #IBSRelief #IBSTreatment #PENFS #DGBI #HealthcareExcellence #Neuromodulation #ChronicPain

Children and adolescents with functional abdominal pain related to IBS deserve a chance to live their lives to the fullest. IB-Stim is a non-surgical, drug-free solution that can help them get back on track. Key Features of IB-Stim: ? Targeted Approach: Delivers gentle electrical impulses into the cranial nerve bundles located in the ear. ? FDA-Cleared: Indicated for functional abdominal pain in patients ages 8-21. ? Minimally Invasive: IB-Stim is a 5-day (120-hour) treatment typically worn for 4 consecutive weeks. Ready to explore IB-Stim for your practice? Visit our website to learn more and access valuable resources: https://lnkd.in/g5gqcUSu See https://lnkd.in/gW6wcdPC?for risks, indications, precautions, and warnings. #IBStim #IBS #FunctionalAbdominalPain #IBSSymptoms #IBSDilemma #IBSawareness #PediatricGI #IrritableBowelSyndrome #ChildIBS #IBSRelief #IBSTreatment #PENFS #DGBI #HealthcareExcellence #PediatricCare #MedicalInnovation #Neuromodulation #ChronicPain

Exciting news! Neuraxis is proud to announce that our latest innovation, the Rectal Expulsion Device (RED), has been grated 510(k) clearance from the FDA. RED is a proprietary, self-inflating balloon that evaluates a patient's ability to expel contents from the rectum. "For many patients with chronic constipation, traditional laxative therapy does not work well because the problem is not related to colon motility, but rather with the neuromuscular function of the pelvic floor," said Dr. Adrian Miranda, Chief Medical Officer for NeurAxis. "Without proper testing, these patients can be missed and continue to suffer with inadequate treatments." RED?can also be used as a qualitative test for rectal hypersensitivity. It will help identify patients who have an exaggerated urge to defecate, which also changes the treatment algorithm for patients with constipation. For important information about RED see: https://lnkd.in/gJSPdZ99 Stay up to date on the latest news for all of Neuraxis' products as it's released by following our investor relations page at:?https://ir.neuraxis.com #Gastroenterology #PediatricGI #GI #DigestiveHealth #GutHealth #Pediatrics #ChildrensHealth #ChronicConstipation

Happy New Year from NeurAxis! As we step into 2025, we remain committed to enhancing lives through innovative therapies like IB-Stim, providing drug-free relief for adolescents ages 8-21 with functional abdominal pain associated with IBS. Together, let's create brighter, healthier futures. Learn more about how we can support your patients this year: https://ibstim.com. See https://lnkd.in/g6cuXJuq for risks, indications, precautions, and warnings. #IBStim #IBS #FunctionalAbdominalPain #IBSSymptoms #IBSawareness #PediatricGI #IrritableBowelSyndrome #ChildIBS